BioVentix PLC Board Appointment (8774A)
30 Mai 2023 - 8:00AM
UK Regulatory
TIDMBVXP
RNS Number : 8774A
BioVentix PLC
30 May 2023
Bioventix plc
("Bioventix" or the "Company")
Board Appointment
Bioventix plc (BVXP), a UK company specialising in the
development and commercial supply of high-affinity monoclonal
antibodies for applications in clinical diagnostics is delighted to
announce that it has appointed Joanne (Jo) Pisani to the Board, as
an independent Non-Executive Director, with immediate effect. Jo
will chair the Company's Audit Committee.
Jo is a chartered engineer with a distinguished background in
the Pharmaceutical, Life Sciences and Biotech sectors. She has held
roles at GSK and BP in strategy, commercial and operational
functions before working in strategic consultancy. She led PwC's UK
Pharmaceutical and Life Sciences practice, assisting clients with
developing strategy, designing and implementing transformational
change and completing M&A transactions.
Jo is a passionate supporter of critical public health issues,
such as tackling dementia, rare diseases and anti-microbial
resistance. She focuses on supporting charities, universities and
business start-ups. She is chair of Birmingham's Precision Health
Technology Accelerator and also chairs the Advisory Board for
London's MedCity. She serves on the boards of the UK Dementia
Research Institute, LifeArc, The RSA Group, London and Partners and
Beacon. She is also a Non-Executive Director and strategic advisor
to biotech companies in the UK, Finland and Spain
Ian Nicholson, Chairman, commented: "The Board is delighted to
welcome Jo to Bioventix. She brings considerable leadership and
strategic experience in Life Sciences and biotech businesses, large
and small, that is highly relevant to Bioventix and the
opportunities being addressed by the Company. I am confident that
she will add considerable value to the Company."
For further information please contact:
Bioventix plc Tel: 01252 728 001
Peter Harrison Chief Executive Officer
Bruce Hiscock Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Simon Hicks Corporate Finance
Alice Lane ECM
Regulatory disclosures
INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G)
OF THE AIM RULES FOR COMPANIES ("AIM RULES")
Full name: Joanne (Jo) Patra Pisani
Age: 58
Shareholding in the Company: No shares held
Current directorships and partnerships:
UK DRI Ltd
Beacon: for rare diseases
Ltd
LAM Action
LifeArc
London & Partners Limited
PHTA Ltd
Ostique Limited
Adora Digital Health Ltd
Elem Biotech SL
Aplagon Oy
RSA (Holdings) Ltd
MedCity Ltd
Historic directorships and partnerships Karoo CGT Limited
in previous 5 years: Pricewaterhouse Coopers
LLP
There is no further information to be disclosed in relation to
the director appointment pursuant to Rule 17 and Schedule 2,
paragraph (g) of the AIM Rules.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNUNVNRONUVUAR
(END) Dow Jones Newswires
May 30, 2023 02:00 ET (06:00 GMT)
Bioventix (AQSE:BVXP.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Bioventix (AQSE:BVXP.GB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024